Ajit Ghosh resumes & CV records
Resumes
Ajit Kumar Ghosh
Ajit K Ghosh, 593119 Crossings Way, Birmingham, AL 35242
Ajit Ghosh Phones & Addresses
3119 Crossings Way, Hoover, AL 35242 205-9958620
5255 Crowne Chase Pkwy, Hoover, AL 35244 205-9829044
1218 Gardens Pl, Birmingham, AL 35216 205-9829044
5017 15Th St, Seattle, WA 98105 206-7299009
Bethlehem, PA
Mentions for Ajit K Ghosh
Publications & IP owners
Us Patents
Aza Nucleosides, Preparation Thereof And Use As Inhibitors Of Rna Viral Polymerases
US Patent:
7560434, Jul 14, 2009
Filed:
Jun 22, 2005
Appl. No.:
11/157867
Inventors:
Yarlagadda S. Babu - Birmingham AL, US
Pooran Chand - Birmingham AL, US
Ajit K. Ghosh - Birmingham AL, US
Pravin L. Kotian - Hoover AL, US
V. Satish Kumar - Birmingham AL, US
Pooran Chand - Birmingham AL, US
Ajit K. Ghosh - Birmingham AL, US
Pravin L. Kotian - Hoover AL, US
V. Satish Kumar - Birmingham AL, US
Assignee:
BioCryst Pharmaceuticals, Inc. - Birmingham AL
International Classification:
A01N 43/04
A61K 31/70
A61K 31/70
US Classification:
514 23, 536 187, 536 292
Abstract:
Compounds represented by the formula:.
Therapeutic Furopyrimidines And Thienopyrimidines
US Patent:
8133870, Mar 13, 2012
Filed:
Oct 28, 2005
Appl. No.:
11/666264
Inventors:
Yarlagadda S. Babu - Birmingham AL, US
Pooran Chand - Birmingham AL, US
Minwan Wu - Vestavia Hills AL, US
Pravin L. Kotian - Hoover AL, US
V. Satish Kumar - Birmingham AL, US
Tsu-Hsing Lin - Vestavia Hills AL, US
Yahya El-Kattan - Vestavia Hills AL, US
Ajit K. Ghosh - Birmingham AL, US
Pooran Chand - Birmingham AL, US
Minwan Wu - Vestavia Hills AL, US
Pravin L. Kotian - Hoover AL, US
V. Satish Kumar - Birmingham AL, US
Tsu-Hsing Lin - Vestavia Hills AL, US
Yahya El-Kattan - Vestavia Hills AL, US
Ajit K. Ghosh - Birmingham AL, US
Assignee:
BioCryst Pharmaceuticals, Inc. - Durham NC
International Classification:
A01N 43/04
A61K 31/70
A61K 31/70
US Classification:
514 23, 536 292
Abstract:
The invention provides compounds of formula I, II, and III as described herein, as well as pharmaceutical compositions comprising the compounds, and synthetic methods and intermediates that are useful for preparing the compounds. The compounds of formula I, II, and III are useful as anti-viral agents and/or as anti-cancer agents.
Hepatitis C Therapies
US Patent:
8163703, Apr 24, 2012
Filed:
Mar 6, 2009
Appl. No.:
12/399521
Inventors:
Yarlagadda S. Babu - Birmingham AL, US
Pooran Chand - Birmingham AL, US
Minwan Wu - Vestavia Hills AL, US
Pravin L. Kotian - Hoover AL, US
V. Satish Kumar - Birmingham AL, US
Tsu-Hsing Lin - Vestavia Hills AL, US
Yahya El-Kattan - Vestavia Hills AL, US
Ajit K. Ghosh - Birmingham AL, US
Pooran Chand - Birmingham AL, US
Minwan Wu - Vestavia Hills AL, US
Pravin L. Kotian - Hoover AL, US
V. Satish Kumar - Birmingham AL, US
Tsu-Hsing Lin - Vestavia Hills AL, US
Yahya El-Kattan - Vestavia Hills AL, US
Ajit K. Ghosh - Birmingham AL, US
Assignee:
BioCryst Pharmaceuticals, Inc. - Birmingham AL
International Classification:
A01N 43/04
A61K 31/70
A61K 31/70
US Classification:
514 23, 536 292
Abstract:
The invention provides methods for treating hepatitis C viral infections and related viral infections, as well as compounds and compositions that are useful for treating such infections.
Therapeutic Furopyrimidines And Thienopyrimidines
US Patent:
2006016, Jul 27, 2006
Filed:
Jan 16, 2006
Appl. No.:
11/332858
Inventors:
Yarlagadda Babu - Birmingham AL, US
Pooran Chand - Birmingham AL, US
Minwan Wu - Vestavia Hills AL, US
Pravin Kotian - Hoover AL, US
V. Kumar - Birmingham AL, US
Tsu-Hsing Lin - Vestavia Hills AL, US
Yahya El-Kattan - Vestavia Hills AL, US
Ajit Ghosh - Birmingham AL, US
Pooran Chand - Birmingham AL, US
Minwan Wu - Vestavia Hills AL, US
Pravin Kotian - Hoover AL, US
V. Kumar - Birmingham AL, US
Tsu-Hsing Lin - Vestavia Hills AL, US
Yahya El-Kattan - Vestavia Hills AL, US
Ajit Ghosh - Birmingham AL, US
International Classification:
A61K 38/21
A61K 31/675
A61K 31/7076
A61K 31/675
A61K 31/7076
US Classification:
424085700, 514045000, 514081000
Abstract:
The invention provides compounds of formula I, II, and III as described herein, as well as pharmaceutical compositions comprising the compounds, and synthetic methods and intermediates that are useful for preparing the compounds. The compounds of formula I, II, and III are useful as anti-viral agents and/or as anti-cancer agents.
Hepatitis C Therapies
US Patent:
2006023, Oct 19, 2006
Filed:
Mar 23, 2006
Appl. No.:
11/388060
Inventors:
Yarlagadda Babu - Birmingham AL, US
Pooran Chand - Birmingham AL, US
Minwan Wu - Vestavia Hills AL, US
Pravin Kotian - Hoover AL, US
V. Kumar - Birmingham AL, US
Tsu-Hsing Lin - Vestavia Hills AL, US
Yahya El-Kattan - Vestavia Hills AL, US
Ajit Ghosh - Birmingham AL, US
Pooran Chand - Birmingham AL, US
Minwan Wu - Vestavia Hills AL, US
Pravin Kotian - Hoover AL, US
V. Kumar - Birmingham AL, US
Tsu-Hsing Lin - Vestavia Hills AL, US
Yahya El-Kattan - Vestavia Hills AL, US
Ajit Ghosh - Birmingham AL, US
International Classification:
C07H 19/22
A61K 31/7064
A61K 31/7064
US Classification:
514043000, 536027100
Abstract:
The invention provides methods for treating hepatitis C viral infections and related viral infections, as well as compounds and compositions that are useful for treating such infections.
Hepatitis C Therapies
US Patent:
2013007, Mar 28, 2013
Filed:
Mar 26, 2012
Appl. No.:
13/430341
Inventors:
Yarlagadda S. Babu - Birmingham AL, US
Pooran Chand - Birmingham AL, US
Minwan Wu - Vestavia Hills AL, US
Pravin L. Kotian - Hoover AL, US
V. Satish Kumar - Birmingham AL, US
Tsu-Hsing Lin - Vestavia Hills AL, US
Yahya El-Kattan - Vestavia Hills AL, US
Ajit K. Ghosh - Birmingham AL, US
Pooran Chand - Birmingham AL, US
Minwan Wu - Vestavia Hills AL, US
Pravin L. Kotian - Hoover AL, US
V. Satish Kumar - Birmingham AL, US
Tsu-Hsing Lin - Vestavia Hills AL, US
Yahya El-Kattan - Vestavia Hills AL, US
Ajit K. Ghosh - Birmingham AL, US
International Classification:
A61K 31/7064
A61K 31/7068
A61K 45/06
A61K 31/7056
A61K 38/22
A61K 38/21
C07H 7/06
C07H 11/04
A61K 31/7068
A61K 45/06
A61K 31/7056
A61K 38/22
A61K 38/21
C07H 7/06
C07H 11/04
US Classification:
424 857, 536 53, 536 55, 514 23, 536 54, 514 43, 514 129, 435184
Abstract:
The invention provides methods for treating hepatitis C viral infections and related viral infections, as well as compounds and compositions that are useful for treating such infections.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.